3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal Carcinoma

3DV+TPS Software Outlines the Outline of Radiotherapy for Nasopharyngeal Carcinoma Center Comparison Study Clinical Research

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03810274

Enrollment

300

Registered

2019-01-18

Start date

2012-02-01

Completion date

2019-01-15

Last updated

2019-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal Carcinoma, Radiotherapy

Brief summary

Comparing the accuracy and speed of 3DV+TPS software with imported TPS and domestic TPS to outline the contours of crisis organs, it is proved that 3DV+TPS has superiority compared with domestic TPS, and it has non-inferiority compared with imported TPS, indicating that the software can improve contour sketching accuracy. And speed, reduce the burden on doctors, improve medical efficiency.

Detailed description

Comparing the accuracy and speed difference between 3DV+TPS software and imported TPS and domestic TPS to outline the contours of crisis organs, the selected organs are: bilateral eyeballs, bilateral crystals, bilateral optic nerves, bilateral parotid glands, oral cavity, spinal cord, brainstem, The brain has a total of 12 organs; verify that 3DV+TPS is superior to domestic TPS, and has non-inferiority compared with imported TPS, Ming software can improve the accuracy and speed of contour sketching, reduce the burden on doctors, and improve medical efficiency.

Interventions

DEVICE3DV+TPS；VARIAN TPS；FonicsPlan

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

1. It is diagnosed as nasopharyngeal carcinoma by histopathological examination, and there is no tumor invasion in the organs that need to be assessed; 2. Age 18-70 years old; 3. There is nasopharynx localization enhanced CT, nasopharynx enhanced MRI.

Exclusion criteria

1. Patient information is incomplete; no age, gender, MRI, height, radiotherapy location CT; 2. The organs at risk that need to be assessed are invaded by the tumor; 3. Any reason cannot be combined with the research or the researcher believes that it is not suitable for inclusion in this test.

Design outcomes

Primary

Measure	Time frame	Description
Sketching accuracy	one year	Define ΔV as a percentage of the total volume of the gold standard;
Sketch speed	one year	Use the stopwatch to record the total time used to draw down 12 organs, to start sketching as the starting point of the time, and to finish the saving of the data.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026